Growth Metrics

Oculis Holding AG (OCS) Depreciation and Depletion (2022 - 2026)

Quarterly Depreciation and Depletion rose 43.75% to $196658.7 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $720851.8 through Mar 2026, up 39.89% year-over-year, with the annual reading at $683138.7 for FY2025, 47.4% up from the prior year.

Oculis Holding AG's Depreciation and Depletion history spans 5 years, with the latest figure at $196658.7 for Q1 2026.

  • Depreciation and Depletion came in at $196658.7 for Q1 2026, down from $197684.8 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $207604.4 in Q4 2022 to a low of $33134.6 in Q3 2022.
  • The 5-year median for Depreciation and Depletion is $136491.6 (2025), against an average of $125414.5.
  • The largest YoY upside for Depreciation and Depletion was 149.43% in 2023 against a maximum downside of 59.82% in 2023.
  • Oculis Holding AG's Depreciation and Depletion stood at $207604.4 in 2022, then tumbled by 59.82% to $83424.2 in 2023, then surged by 66.94% to $139265.7 in 2024, then surged by 41.95% to $197684.8 in 2025, then fell by 0.52% to $196658.7 in 2026.
  • Per Business Quant, the three most recent readings for OCS's Depreciation and Depletion are $196658.7 (Q1 2026), $197684.8 (Q4 2025), and $190016.6 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1,395.22
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 196,658.72

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 196,658.72
Mar 31, 2026 196,658.72
Dec 31, 2025 197,684.83
Dec 31, 2025 197,684.83
Sep 30, 2025 190,016.65
Sep 30, 2025 190,016.65
Jun 30, 2025 136,491.60
Jun 30, 2025 136,491.60
Mar 31, 2025 136,806.82
Mar 31, 2025 136,806.82
Dec 31, 2024 139,265.67
Dec 31, 2024 139,265.67
Sep 30, 2024 140,813.28
Sep 30, 2024 140,813.28
Jun 30, 2024 98,415.62
Jun 30, 2024 98,415.62
Mar 31, 2024 83,634.81
Mar 31, 2024 83,634.81
Dec 31, 2023 83,424.23
Dec 31, 2023 83,424.23
Sep 30, 2023 82,647.14
Sep 30, 2023 82,647.14
Jun 30, 2023 116,778.43
Jun 30, 2023 116,778.43
Mar 31, 2023 37,840.69
Mar 31, 2023 37,840.69
Dec 31, 2022 207,604.38
Dec 31, 2022 207,604.38
Sep 30, 2022 33,134.61
Sep 30, 2022 33,134.61